Remus Pharmaceuticals Ltd.

₹722.7

Remus Pharmaceuticals Ltd.

  • NSE : REMUS
Add Alert
Add Watchlist

₹722.7

₹722.7

3.25 (0.45%) - 3 Oct 2025 09:21 AM
  • NSE : REMUS

About Company

Remus Pharmaceuticals limited is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, its clients are spread in various countries. It looks forward to form long lasting relationships that enhance the lives of its patients.

Market Cap. ₹ 852 Cr.
52 Week - High/Low ₹ 0/0
P/E Ratio 22.84
P/B Ratio 10.38
Enterprise Value ₹ 875 Cr.
ROE % 33.24
RSI Value 20.60
EMA 50 949.4
EMA 200 1541.43
Market Cap. ₹ 852 Cr.
52 Week - High/Low ₹ 0/0
P/E Ratio 16.71
P/B Ratio 9.80
Enterprise Value ₹ 873 Cr.
ROE % 29.91
RSI Value 20.60
EMA 50 949.4
EMA 200 1541.43

Valuation

Calculators

Peer Comparison

Industry - Trading

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.